Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%

FDA Drug Profile — Revivol Hemorrhoid and Fissure, DCH Hemorrhoidal, Walgreens Hemorrhoidal Pain Relief

Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25% is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Revivol Hemorrhoid and Fissure, DCH Hemorrhoidal, Walgreens Hemorrhoidal Pain Relief. Available dosage form: cream.

Drug details

Generic Name
Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%
Brand Names
Revivol Hemorrhoid and Fissure, DCH Hemorrhoidal, Walgreens Hemorrhoidal Pain Relief
Application Number
M015
Sponsor
Derma Care Research Labs, LLC
NDC Codes
3
Dosage Forms
CREAM
Routes
TOPICAL
Active Ingredients
LIDOCAINE, PETROLATUM, GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE

Indications and Usage

For the temporary relief of pain, soreness, and burning. Helps relieve the local itching and discomfort associated with hemorrhoids. Temporarily shrinks hemorrhoidal tissue. Temporarily provides a coating for the relief of anorectal discomforts. Temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful.

Warnings

For external use only. Ask a doctor before use if you have: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland. Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product : avoid contact with eyes, do not exceed recommended dosage unless directed by a doctor, do not put this product into rectum by using fingers or any mechanical device or applicator. Stop use and ask a doctor if : rectal bleeding occurs, condition worsens or does not improve within seven (7) days, allergic reaction occurs to ingredients in this product, symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, symptoms clear up and return within a few days.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.